Clinical Trials Sponsored by Ferring Pharmaceuticals Korea, Ltd.

Total 108 results

Ferring Pharmaceuticals
Ferring Pharmaceuticals Korea, Ltd.

Completed

Efficacy and Safety of Degarelix One Month Dosing Regimen in Korean Patients With Prostate Cancer

Prostate Cancer

Korea, Republic of
Ferring Pharmaceuticals
Ferring Pharmaceuticals Korea, Ltd.

Completed

Long-Term Safety and Tolerability of Degarelix One-Month Dosing Regimen in Korean Patients

Prostate Cancer

Korea, Republic of
Trio Medicines Ltd.
Ferring Pharmaceuticals

Completed

Effect of 5, 10 or 25 mg of YF476 Daily for 14 Days on Stomach Acidity in Healthy Volunteers

Reflux Oesophagitis

United Kingdom
Trio Medicines Ltd.
Ferring Pharmaceuticals

Completed

Effect of Repeated Doses of YF476, Omeprazole and Placebo on Stomach Acidity in Healthy Volunteers

Reflux Oesophagitis

United Kingdom
Trio Medicines Ltd.
Ferring Pharmaceuticals

Completed

Safety, Tolerability and Pharmacokinetics of Single Rising Doses of YF476, a Gastrin Antagonist, in Healthy Men

Reflux Oesophagitis

United Kingdom
Trio Medicines Ltd.
Ferring Pharmaceuticals

Completed

Effect of Single Doses of YF476 on Stomach Acidity Compared With Ranitidine and Placebo in Fasted and Fed States

Reflux Oesophagitis

United Kingdom
Korea Otsuka Pharmaceutical Co., Ltd.

Active, not recruiting

Iclusig PMS in CML or Ph+ALL Patients

Chronic Myeloid Leukemia | Philadelphia Chromosome-positive Acute Lymphoblastic Leukemia

Korea, Republic of
Korea Otsuka Pharmaceutical Co., Ltd.

Completed

Open-label, Extension Study of CDP870 in Patients With Rheumatoid Arthritis

Rheumatoid Arthritis
Korea Otsuka Pharmaceutical Co., Ltd.

Completed

Pharmacokinetics Study for Probucol

Healthy

Korea, Republic of
Korea Otsuka Pharmaceutical Co., Ltd.

Completed

Abilify Maintena PMS in Schizophrenia Patients or Bipolar 1 Disorder

Schizophrenia | Bipolar 1 Disorder

Korea, Republic of
Korea Otsuka Pharmaceutical Co., Ltd.

Completed

A Study to Evaluate the Efficacy and Safety of MCT-SR in Patients With Gastritis

Acute Gastritis | Chronic Gastritis

Korea, Republic of
Korea Otsuka Pharmaceutical Co., Ltd.

Terminated

A Phase I, Open Label, Non Randomized, Multicenter, Dose Escalation Clinical Study to Investigate Safety and Tolerability of OPB(Otsuka Pharmaceutical Biwa)-111077 in Subjects With Advanced HCC(Hepatocellular Carcinoma)

Advanced Hepatocellular Carcinoma

Korea, Republic of
Korea Otsuka Pharmaceutical Co., Ltd.

Completed

Efficacy and Safety of Aripiprazole in Patients With Schizophrenia or Bipolar Disorder

Schizophrenia | Bipolar Disorder

Korea, Republic of
Korea Otsuka Pharmaceutical Co., Ltd.

Completed

A Study of CDP870 as Add-on Meditation to Methotrexate (MTX) in Patients With Rheumatoid Arthritis

Rheumatoid Arthritis

Korea, Republic of
Korea Otsuka Pharmaceutical Co., Ltd.

Completed

Evaluate the Efficacy and Safety of Pletaal (Cilostazol) in Subjects With Vasospastic Angina (STELLA)

Variant Angina

Korea, Republic of
Korea Otsuka Pharmaceutical Co., Ltd.

Completed

SWitching to Abilify Trial (SWAT)

Schizophrenia

Korea, Republic of
Korea Otsuka Pharmaceutical Co., Ltd.

Recruiting

A Study of Abilify® Tablet(Aripiprazole) as an Adjunctive Treatment in the Bipolar Depression (APOLLO)

Depression, Bipolar

Korea, Republic of
Korea Otsuka Pharmaceutical Co., Ltd.

Recruiting

Samsca PMS in ADPKD Patients

Safety

Korea, Republic of
Korea Otsuka Pharmaceutical Co., Ltd.

Terminated

Effect of Samsca on Control of Hyponatremia and Extracellular Fluid in Cirrhotic Patients With Ascites (ECF)

Hyponatremia and Extracellular Fluid in Cirrhotic

Korea, Republic of
Korea Otsuka Pharmaceutical Co., Ltd.

Completed

Post Marketing Registry to Assess Usage, Safety and Effectiveness of Deltyba Tablets in Korean Patients With MDR-TB

Multi-drug Resistant Tuberculosis

Korea, Republic of
Korea Otsuka Pharmaceutical Co., Ltd.

Completed

Samsca Post Marketing Surveillance Study (Samsca PMS)

Hypervolemic and Euvolemic Hyponatremia

Korea, Republic of
Korea Otsuka Pharmaceutical Co., Ltd.

Completed

To Evaluate Food Effect on the Pharmacokinetics of Rebamipide in Healthy Volunteers

Healthy Volunteers

Korea, Republic of
Korea Otsuka Pharmaceutical Co., Ltd.

Completed

Safety and Efficacy Study of Cilostazol to Treat Vasospastic Angina (STELLA_Ext)

Vasospastic Angina

Korea, Republic of
Korea Otsuka Pharmaceutical Co., Ltd.

Completed

PReventive Efficacy and Safety of rEbamipide on Nsaid Induced Mucosal Toxicity (PRESENT)

Osteoarthritis | Rheumatoid Arthritis | Ankylosing Spondylitis

Korea, Republic of
Korea Otsuka Pharmaceutical Co., Ltd.

Completed

Abilify in Bipolar Disorder for 24 Weeks Treatment Effectiveness (SMART-M)

Bipolar Disorder

Korea, Republic of
Korea Otsuka Pharmaceutical Co., Ltd.

Completed

Abilify in Bipolar Disorder for 6 Weeks Treatment Effectiveness (SMART-A)

Bipolar Disorder

Korea, Republic of
Korea Otsuka Pharmaceutical Co., Ltd.

Completed

Acute Psychosis Treatment in the Long Term, Unitary Group Study (APLUS)

Schizophrenia | Schizoaffective Disorder

Korea, Republic of
Korea Otsuka Pharmaceutical Co., Ltd.

Unknown

An Open-Label Phase-1 Study of OPB-31121 in Patients With Advanced Solid Tumors

Solid Tumor

Korea, Republic of
Korea Otsuka Pharmaceutical Co., Ltd.

Not yet recruiting

Registry on the Effectiveness and Safety of the 9-month MDR-END Treatment Regimen in Korean Patients with FQ-sensitive MDR-TB (MDR-END Registry)

Tuberculosis, Multidrug-Resistant
Korea Otsuka Pharmaceutical Co., Ltd.

Recruiting

Post-Marketing Surveillance of Safety and Effectiveness of Mucosta®SR Tab. (MCTSRPMS)

Acute Gastritis | Chronic Gastritis

Korea, Republic of
Korea Otsuka Pharmaceutical Co., Ltd.

Completed

Evaluation of Concomitant Administration of Cilostazol and Probucol on Biomarkers, Endothelial Function and Safety

Peripheral Artery Disease

Korea, Republic of
Korea Otsuka Pharmaceutical Co., Ltd.

Completed

Evaluating the Safety and effectivenesS in Adult KorEaN Patients Treated With Tolvaptan for Management of Autosomal domInAnt poLycystic Kidney Disease (ESSENTIAL)

Autosomal Dominant Polycystic Kidney Disease (ADPKD)

Korea, Republic of
Korea Otsuka Pharmaceutical Co., Ltd.

Completed

A Study to Evaluate the Efficacy and Safety of Pletaal SR Capsule (Cilostazol) in Subjects With Peripheral Arterial Disease Symptom Due to Chronic Occlusive Arterial Disease

Chronic Occlusive Arterial Disease

Korea, Republic of
Korea Otsuka Pharmaceutical Co., Ltd.

Completed

MAintain the Efficacy and Safety in Treatment of Schizophrenia After Switching to Long-acTing Injectable aRipiprazole From Oral Atypical Antipsychotics (MAESTRO)

Schizophrenia | Antipsychotics | Long-Acting Injection | LAI | Aripiprazole

Korea, Republic of
Korea Otsuka Pharmaceutical Co., Ltd.

Completed

To Evaluate Pharmacokinetics and Safety of Two Different Formulation of Rebamipide in Healthy Volunteers

Healthy Volunteers

Korea, Republic of
Korea Otsuka Pharmaceutical Co., Ltd.

Completed

ABF Tourette's Disorder Post Marketing Surveillance Study

Tourette's Disorder

Korea, Republic of
Korea Otsuka Pharmaceutical Co., Ltd.

Completed

Pletaal SR Post Marketing Observational Study (PLTSRPMOS)

Cerebral Infarction | Ischemic Symptoms

Korea, Republic of
Korea Otsuka Pharmaceutical Co., Ltd.

Terminated

Outcome and Treatment Quality Study of Tolvaptan to Treat Hyponatremia in Patients With Heart Failure (AQUATIC)

Heart Failure With Hyponatremia

Korea, Republic of
Korea Otsuka Pharmaceutical Co., Ltd.

Completed

A Therapeutic Confirmatory Study to Evaluate the Efficacy and Safety of Cilostazol in Subjects With Vasospastic Angina (STELLA)

Vasospastic Angina

Korea, Republic of
Korea Otsuka Pharmaceutical Co., Ltd.

Completed

Efficacy and Safety Study of Probucol in Patients With Diabetic Nephropathy

Diabetic Nephropathy

Korea, Republic of
Korea Otsuka Pharmaceutical Co., Ltd.

Completed

Pharmacokinetics/Pharmacodynamics (PK/PD) Characteristics of Tolvaptan Tablet in Korean Healthy Male

Healthy

Korea, Republic of
Korea Otsuka Pharmaceutical Co., Ltd.

Completed

Efficacy and Safety of Cilostazol for the Indication of CSPS

Cerebral Infarction

Korea, Republic of
Otsuka Pharmaceutical Co., Ltd.
Korea Otsuka Pharmaceutical Co., Ltd.

Completed

A Phase 2 Trial to Evaluate the Efficacy and Safety of OCV-501 in Elderly Patients With Acute Myeloid Leukemia

Acute Myeloid Leukemia

Taiwan, Korea, Republic of, Japan
Korea Otsuka Pharmaceutical Co., Ltd.
Otsuka Pharmaceutical Co., Ltd.

Completed

Safety and Biomarker of OPB-111077 in Subjects With Advanced Solid Tumor

Solid Tumor

Korea, Republic of
Korea Otsuka Pharmaceutical Co., Ltd.
Otsuka Pharmaceutical Co., Ltd.

Completed

Safety and Pharmacokinetics of Probucol and Cilostazol

Healthy

Korea, Republic of
Korea Otsuka Pharmaceutical Co., Ltd.
Otsuka Pharmaceutical Co., Ltd.

Completed

OPS-2071 Single and Multiple Dose Study to Investigate PK and PD Profile in Healthy Korean Male Subjects. (OPS-2071Ph1)

Healthy

Korea, Republic of
Korea Otsuka Pharmaceutical Co., Ltd.
Otsuka Pharmaceutical Co., Ltd.

Completed

Aripiprazole in Children and Adolescents With Chronic Tic Disorder or Tourette's Disorder

Tourette's Disorder | Chronic Motor or Vocal Tic Disorder

Korea, Republic of
Korea Otsuka Pharmaceutical Co., Ltd.
Otsuka Pharmaceutical Co., Ltd.

Unknown

Observational Study of Anti-Cancer Therapy Induced Oral Mucositis in Korean Cancer Patients

Oral Mucositis

Korea, Republic of
Korea Otsuka International Asia Arab
Korea Otsuka Pharmaceutical Co., Ltd.; Zhejiang Otsuka Pharmaceutical Co.,...

Completed

Healing Effects of Rebamipide and Omeprazole in Helicobacter Pylori-positive Gastric Ulcer After Eradication Therapy

Stomach Ulcer

China, Korea, Republic of
Chonbuk National University Hospital
AstraZeneca; Sanofi-Synthelabo; Janssen Korea, Ltd., Korea; Korea Otsuka Pharmaceutical...

Completed

Different Safety Profile of Risperidone and Paliperidone Extended-release

Schizophrenia

Korea, Republic of

Clinical Trials Sponsored by Ferring Pharmaceuticals Korea, Ltd.

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Portugal

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations